MedTech 2024: Deep Dive into Investment Trends — What Moved, What Slipped, and What It Signals

MedTech investment in 2024 presented a nuanced picture, with venture capital and M&A resurging, but a clear shift towards disciplined investment. We found capital heavily favored later-stage companies with commercialized products, propelling non-invasive monitoring and orthopedics forward while early-stage deals and certain verticals like diagnostics faced increased scrutiny. This trend underscores a rising demand for proven clinical and commercial readiness, which will continue to shape the sector's trajectory.

Piyush Bhardwaj

9/23/20251 min read

MedTech 2024: Deep Dive into Investment Trends — What Moved, What Slipped, and What It Signals